Inherited Channelopathies of Muscle. Implications for Therapy

Theodore Cummins, Robert L. Ruff

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter examines how disease mutations alter the function of different muscle ion channels and illustrates how these changes in ion channel properties contribute to the pathophysiological mechanisms underlying muscle disorders. A specific ion channel mutation can contribute to distinct disorders or exhibit different patterns of inheritance in different families. Thus, it is clear that genetic and environmental modifiers play important roles in determining the clinical phenotype. Furthermore, calcium channel mutations, which may cause hypokalemic periodic paralysis (HypoPP) by reducing sodium and potassium current densities, may represent indirect channelopathies. Moreover, some of the inherited muscle disorders, such as the myotonic sodium channel disorders, are treated by agents that largely target symptoms but not the cause of the disease, but others such as malignant hyperthermia (MH) can be treated by agents that specifically target the defective molecule. Though, channelopathies are typically rare, the insights gained from studying these genetic mutations should aid in the development of better treatments for excitability disorders.

Original languageEnglish
Title of host publicationFrom NEUROSCIENCE To NEUROLOGY
PublisherElsevier Inc.
Pages303-318
Number of pages16
ISBN (Print)9780127389035
DOIs
StatePublished - 2005

Fingerprint

Channelopathies
Ion Channels
Muscles
Mutation
Muscular Diseases
Hypokalemic Periodic Paralysis
Malignant Hyperthermia
Inheritance Patterns
Sodium Channels
Calcium Channels
Therapeutics
Potassium
Sodium
Phenotype

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Cummins, T., & Ruff, R. L. (2005). Inherited Channelopathies of Muscle. Implications for Therapy. In From NEUROSCIENCE To NEUROLOGY (pp. 303-318). Elsevier Inc.. https://doi.org/10.1016/B978-012738903-5/50019-9

Inherited Channelopathies of Muscle. Implications for Therapy. / Cummins, Theodore; Ruff, Robert L.

From NEUROSCIENCE To NEUROLOGY. Elsevier Inc., 2005. p. 303-318.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cummins, T & Ruff, RL 2005, Inherited Channelopathies of Muscle. Implications for Therapy. in From NEUROSCIENCE To NEUROLOGY. Elsevier Inc., pp. 303-318. https://doi.org/10.1016/B978-012738903-5/50019-9
Cummins T, Ruff RL. Inherited Channelopathies of Muscle. Implications for Therapy. In From NEUROSCIENCE To NEUROLOGY. Elsevier Inc. 2005. p. 303-318 https://doi.org/10.1016/B978-012738903-5/50019-9
Cummins, Theodore ; Ruff, Robert L. / Inherited Channelopathies of Muscle. Implications for Therapy. From NEUROSCIENCE To NEUROLOGY. Elsevier Inc., 2005. pp. 303-318
@inbook{718179c67a3a45479eb3f0a26935a4da,
title = "Inherited Channelopathies of Muscle. Implications for Therapy",
abstract = "This chapter examines how disease mutations alter the function of different muscle ion channels and illustrates how these changes in ion channel properties contribute to the pathophysiological mechanisms underlying muscle disorders. A specific ion channel mutation can contribute to distinct disorders or exhibit different patterns of inheritance in different families. Thus, it is clear that genetic and environmental modifiers play important roles in determining the clinical phenotype. Furthermore, calcium channel mutations, which may cause hypokalemic periodic paralysis (HypoPP) by reducing sodium and potassium current densities, may represent indirect channelopathies. Moreover, some of the inherited muscle disorders, such as the myotonic sodium channel disorders, are treated by agents that largely target symptoms but not the cause of the disease, but others such as malignant hyperthermia (MH) can be treated by agents that specifically target the defective molecule. Though, channelopathies are typically rare, the insights gained from studying these genetic mutations should aid in the development of better treatments for excitability disorders.",
author = "Theodore Cummins and Ruff, {Robert L.}",
year = "2005",
doi = "10.1016/B978-012738903-5/50019-9",
language = "English",
isbn = "9780127389035",
pages = "303--318",
booktitle = "From NEUROSCIENCE To NEUROLOGY",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Inherited Channelopathies of Muscle. Implications for Therapy

AU - Cummins, Theodore

AU - Ruff, Robert L.

PY - 2005

Y1 - 2005

N2 - This chapter examines how disease mutations alter the function of different muscle ion channels and illustrates how these changes in ion channel properties contribute to the pathophysiological mechanisms underlying muscle disorders. A specific ion channel mutation can contribute to distinct disorders or exhibit different patterns of inheritance in different families. Thus, it is clear that genetic and environmental modifiers play important roles in determining the clinical phenotype. Furthermore, calcium channel mutations, which may cause hypokalemic periodic paralysis (HypoPP) by reducing sodium and potassium current densities, may represent indirect channelopathies. Moreover, some of the inherited muscle disorders, such as the myotonic sodium channel disorders, are treated by agents that largely target symptoms but not the cause of the disease, but others such as malignant hyperthermia (MH) can be treated by agents that specifically target the defective molecule. Though, channelopathies are typically rare, the insights gained from studying these genetic mutations should aid in the development of better treatments for excitability disorders.

AB - This chapter examines how disease mutations alter the function of different muscle ion channels and illustrates how these changes in ion channel properties contribute to the pathophysiological mechanisms underlying muscle disorders. A specific ion channel mutation can contribute to distinct disorders or exhibit different patterns of inheritance in different families. Thus, it is clear that genetic and environmental modifiers play important roles in determining the clinical phenotype. Furthermore, calcium channel mutations, which may cause hypokalemic periodic paralysis (HypoPP) by reducing sodium and potassium current densities, may represent indirect channelopathies. Moreover, some of the inherited muscle disorders, such as the myotonic sodium channel disorders, are treated by agents that largely target symptoms but not the cause of the disease, but others such as malignant hyperthermia (MH) can be treated by agents that specifically target the defective molecule. Though, channelopathies are typically rare, the insights gained from studying these genetic mutations should aid in the development of better treatments for excitability disorders.

UR - http://www.scopus.com/inward/record.url?scp=84882539433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882539433&partnerID=8YFLogxK

U2 - 10.1016/B978-012738903-5/50019-9

DO - 10.1016/B978-012738903-5/50019-9

M3 - Chapter

SN - 9780127389035

SP - 303

EP - 318

BT - From NEUROSCIENCE To NEUROLOGY

PB - Elsevier Inc.

ER -